Non-Hodgkin Lymphoma
Showing NaN - NaN of 35
Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,
Completed
- Anaplastic Large-Cell Lymphoma
- +2 more
- brentuximab vedotin
- +4 more
-
Gilbert, Arizona
- +143 more
Nov 1, 2021
Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)
Completed
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Camidanlumab tesirine
-
Duarte, California
- +11 more
Jul 12, 2021
Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood
Completed
- Hematological Malignancy
- +5 more
- Cord blood stem cells
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 20, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)
Terminated
- Lymphoid Malignancies
- +3 more
- Romidepsin
- Oral 5-Azacitidine
-
New York, New YorkColumbia University Medical Center
Jan 5, 2021
Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)
Unknown status
- Lymphoid Malignancies
- +4 more
-
Boston, Massachusetts
- +1 more
Feb 6, 2020
The Second Multicenter Hemophilia Cohort Study
Completed
- Liver Decompensation
- +2 more
-
Tucson, Arizona
- +47 more
Dec 14, 2019
Non-Hodgkin Lymphoma Trial in United States (SGN-40 (anti-huCD40 mAb))
Completed
- Non-Hodgkin Lymphoma
- SGN-40 (anti-huCD40 mAb)
-
Birmingham, Alabama
- +4 more
Dec 17, 2014
